Navigation Links
ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
Date:7/14/2009

Kelly Larrabee, Director, Clinical Services, will lead a panel of life sciences executives on the topic of "Capitalizing on Trends in Negotiation, Contracts, and Risk and Reward." Discussion will center around risk/reward approaches and technology collaboration among clinical trial sponsors and service providers such as clinical research organizations.

Washington, DC (PRWEB) July 14, 2009 -- ClearTrial (www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Kelly Larrabee, Director, Clinical Services, will lead a panel of life sciences executives on the topic of "Capitalizing on Trends in Negotiation, Contracts, and Risk and Reward." The panel discussion, taking place this week at the ExL Effective Business Development for Clinical Trial Service Providers conference in the nation's capital, will give attendees the opportunity to gain practical guidelines for successful trial sponsor/service provider agreements, including the latest trends in bundling services and collaborative technology partnerships.

In addition, attendees will discover:

 
  • How contracting approaches and processes -- such as RFP review, contract structure, metrics and oversight -- have changed due to industry conditions.
  • How service providers are successfully utilizing methodologies from other industries for direct cost savings, including lean six sigma, activity-based costing, and earned value management.
  • The effectiveness of outcomes-based pricing: risk-based services versus fixed price.
For more information on the conference, visit http://www.exlpharma.com/eventAgenda.php?id=174.

Larrabee brings more than 17 years of clinical operations and clinical project management experience, with both trial sponsors and service providers, to the ExL conference. Prior to joining ClearTrial, she was Associate Director, Clinical Operations for Quintiles, where she oversaw the management of Clinical Research Associates for the Functional Service Provider group for a global sponsor company and led process improvement initiatives related to managing the closure of non-enrolling sites. Before Quintiles, Larrabee was Manager and Regional Study Lead for Pfizer, where she directed project site protocol deliverables for pilot, phase I and phase II oncology studies, and managed the Pfizer Investigator Training Program for the Western Region. Previously, she was Manager, Research Compliance for MD Anderson Cancer Center.

About ClearTrial®
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial's award-winning software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2637414.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
2. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
3. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
4. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
5. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
6. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
7. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
8. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
9. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
10. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
11. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... , ... August 16, 2017 , ... ... into a different cell type. Many treatments for specific cancers, such as breast, ... of targeted treatment is androgen deprivation therapy for advanced prostate cancer. , ...
(Date:8/16/2017)... OXFORD, England , Aug. 16, 2017  Kingfisher ... executive search and leadership development, and Virdis Group, global executive ... an exclusive alliance that enables clients to leverage the expertise ... "For our clients here in the Boston ... a diverse population of leadership talent throughout the US, ...
(Date:8/15/2017)... ... ... Any expert in stem cell research or stem cell medicine knows well the ... Despite their essential roles in human health and regenerative medicine, adult tissue stem ... this purpose also tag other, more abundant, non-stem tissue cells ( See 2017 Cell ...
(Date:8/14/2017)... ... August 14, 2017 , ... Every ... Key researchers in the antibody community have recently come together to address this ... in the laboratory. , The team at Thermo Fisher Scientific ...
Breaking Biology Technology:
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... NEW YORK , March 21, 2017 /PRNewswire/ ... Customer Marketing Cloud used by retailers such as ... in its platform — Product Recommendations and Replenishment. Using ... to give more personalized product and replenishment recommendations ... purchases, but also on predictions of customer intent ...
Breaking Biology News(10 mins):